{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:58:24Z","timestamp":1782925104717,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This work was supported by a grant from the French Ministry of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Dyspnea is a key symptom of de novo acute hypoxemic respiratory failure. This study explores dyspnea and its association with intubation and mortality in this population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This was a secondary analysis of a multicenter, randomized, controlled trial. Dyspnea was quantified by a visual analog scale (dyspnea-VAS) from zero to 100\u00a0mm. Dyspnea was measured in 259 of the 310 patients included. Factors associated with intubation were assessed with a competing risks model taking into account ICU discharge. The Cox model was used to evaluate factors associated with 90-day mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>At baseline (randomization in the parent trial), median dyspnea-VAS was 46 (interquartile range, 16\u201365) mm and was\u2009\u2265\u200940\u00a0mm in 146 patients (56%). The intubation rate was 45%. Baseline variables independently associated with intubation were moderate (dyspnea-VAS 40\u201364\u00a0mm) and severe (dyspnea-VAS\u2009\u2265\u200965\u00a0mm) dyspnea at baseline (sHR 1.96 and 2.61, <jats:italic>p<\/jats:italic>\u2009=\u20090.023), systolic arterial pressure (sHR 2.56, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), heart rate (sHR 1.94, <jats:italic>p<\/jats:italic>\u2009=\u20090.02) and PaO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub> (sHR 0.34, <jats:italic>p<\/jats:italic>\u2009=\u20090.028). 90-day mortality was 20%. The cumulative probability of survival was lower in patients with baseline dyspnea-VAS\u2009\u2265\u200940\u00a0mm (logrank test, <jats:italic>p<\/jats:italic>\u2009=\u20090.049). Variables independently associated with mortality were SAPS 2\u2009\u2265\u200925 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), moderate-to-severe dyspnea at baseline (<jats:italic>p<\/jats:italic>\u2009=\u20090.073), PaO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub> (<jats:italic>p<\/jats:italic>\u2009=\u20090.118), and treatment arm (<jats:italic>p<\/jats:italic>\u2009=\u20090.046).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In patients admitted to the ICU for de novo acute hypoxemic respiratory failure, dyspnea is associated with a higher risk of intubation and with a higher mortality.<\/jats:p>\n            <jats:p>\n              <jats:bold>Trial registration<\/jats:bold>: clinicaltrials.gov Identifier # NCT 01320384.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13054-024-04903-5","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T13:02:26Z","timestamp":1716469346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dyspnea is severe and associated with a higher intubation rate in de novo acute hypoxemic respiratory failure"],"prefix":"10.1186","volume":"28","clinical-trial-number":[{"clinical-trial-number":"nct01320384","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Alexandre","family":"Demoule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Baptiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud W.","family":"Thille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Similowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Ragot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gw\u00e9nael","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Mercat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Girault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Carteaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Boulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Perbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxens","family":"Decav\u00e8le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Belin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Frat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"from the REVA Network (Research Network in Mechanical Ventilation)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"4903_CR1","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","volume":"372","author":"J-P Frat","year":"2015","unstructured":"Frat J-P, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2185\u201396.","journal-title":"N Engl J Med"},{"key":"4903_CR2","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1164\/rccm.200402-226OC","volume":"172","author":"E L\u2019Her","year":"2005","unstructured":"L\u2019Her E, Deye N, Lellouche F, Taille S, Demoule A, Fraticelli A, et al. Physiologic effects of noninvasive ventilation during acute lung injury. Am J Respir Crit Care Med. 2005;172:1112\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"4903_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00134-015-4087-4","volume":"42","author":"A Demoule","year":"2016","unstructured":"Demoule A, Chevret S, Carlucci A, Kouatchet A, Jaber S, Meziani F, et al. Changing use of noninvasive ventilation in critically ill patients: trends over 15 years in francophone countries. Intensive Care Med. 2016;42:82\u201392.","journal-title":"Intensive Care Med"},{"key":"4903_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s00134-012-2475-6","volume":"38","author":"A Carrillo","year":"2012","unstructured":"Carrillo A, Gonzalez-Diaz G, Ferrer M, Martinez-Quintana ME, Lopez-Martinez A, Llamas N, et al. Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure. Intensive Care Med. 2012;38:458\u201366.","journal-title":"Intensive Care Med"},{"key":"4903_CR5","doi-asserted-by":"publisher","first-page":"R269","DOI":"10.1186\/cc13103","volume":"17","author":"AW Thille","year":"2013","unstructured":"Thille AW, Contou D, Fragnoli C, Cordoba-Izquierdo A, Boissier F, Brun-Buisson C. Non-invasive ventilation for acute hypoxemic respiratory failure: intubation rate and risk factors. Crit Care. 2013;17:R269.","journal-title":"Crit Care"},{"key":"4903_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1164\/rccm.201606-1306OC","volume":"195","author":"G Bellani","year":"2017","unstructured":"Bellani G, Laffey JG, Pham T, Madotto F, Fan E, Brochard L, et al. Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE study. Am J Respir Crit Care Med. 2017;195:67\u201377.","journal-title":"Am J Respir Crit Care Med"},{"key":"4903_CR7","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1007\/s00134-001-1114-4","volume":"27","author":"M Antonelli","year":"2001","unstructured":"Antonelli M, Conti G, Moro ML, Esquinas A, Gonzalez-Diaz G, Confalonieri M, et al. Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med. 2001;27:1718\u201328.","journal-title":"Intensive Care Med"},{"key":"4903_CR8","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1164\/rccm.201803-0589OC","volume":"199","author":"O Roca","year":"2019","unstructured":"Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hern\u00e1ndez G, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019;199:1368\u201376.","journal-title":"Am J Respir Crit Care Med"},{"key":"4903_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/CCM.0000000000002818","volume":"46","author":"J-P Frat","year":"2018","unstructured":"Frat J-P, Ragot S, Coudroy R, Constantin J-M, Girault C, Prat G, et al. Predictors of intubation in patients with acute hypoxemic respiratory failure treated with a noninvasive oxygenation strategy. Crit Care Med. 2018;46:208\u201315.","journal-title":"Crit Care Med"},{"key":"4903_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/CCM.0000000000001379","volume":"44","author":"G Carteaux","year":"2016","unstructured":"Carteaux G, Mill\u00e1n-Guilarte T, De Prost N, Razazi K, Abid S, Thille AW, et al. Failure of noninvasive ventilation for de novo acute hypoxemic respiratory failure: role of tidal volume. Crit Care Med. 2016;44:282\u201390.","journal-title":"Crit Care Med"},{"key":"4903_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00134-023-07246-x","volume":"50","author":"A Demoule","year":"2024","unstructured":"Demoule A, Decavele M, Antonelli M, Camporota L, Abroug F, Adler D, et al. Dyspnoea in acutely ill mechanically ventilated adult patients: an ERS\/ESICM statement. Intensive Care Med. 2024;50:159\u201380.","journal-title":"Intensive Care Med"},{"key":"4903_CR12","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1007\/s00134-013-2910-3","volume":"39","author":"M Schmidt","year":"2013","unstructured":"Schmidt M, Kindler F, Gottfried SB, Raux M, Hug F, Similowski T, et al. Dyspnea and surface inspiratory electromyograms in mechanically ventilated patients. Intensive Care Med. 2013;39:1368\u201376.","journal-title":"Intensive Care Med"},{"key":"4903_CR13","doi-asserted-by":"publisher","first-page":"1702637","DOI":"10.1183\/13993003.02637-2017","volume":"52","author":"L Dangers","year":"2018","unstructured":"Dangers L, Montlahuc C, Kouatchet A, Jaber S, Meziani F, Perbet S, et al. Dyspnoea in patients receiving noninvasive ventilation for acute respiratory failure: prevalence, risk factors and prognostic impact: a prospective observational study. Eur Respir J. 2018;52:1702637.","journal-title":"Eur Respir J"},{"key":"4903_CR14","doi-asserted-by":"publisher","first-page":"00418","DOI":"10.1183\/23120541.00418-2021","volume":"7","author":"LS Menga","year":"2021","unstructured":"Menga LS, Grieco DL, Ros\u00e0 T, Cesarano M, Delle Cese L, Berardi C, et al. Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure: post hoc analysis of a randomised clinical trial. ERJ Open Res. 2021;7:00418\u20132021.","journal-title":"ERJ Open Res"},{"key":"4903_CR15","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1001\/jama.2022.15613","volume":"328","author":"J-P Frat","year":"2022","unstructured":"Frat J-P, Quenot J-P, Badie J, Coudroy R, Guitton C, Ehrmann S, et al. Effect of high-flow nasal cannula oxygen vs standard oxygen therapy on mortality in patients with respiratory failure due to COVID-19: the SOHO-COVID randomized clinical trial. JAMA. 2022;328:1212\u201322.","journal-title":"JAMA"},{"key":"4903_CR16","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1001\/jama.2018.14282","volume":"320","author":"E Azoulay","year":"2018","unstructured":"Azoulay E, Lemiale V, Mokart D, Nseir S, Argaud L, P\u00e8ne F, et al. Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial. JAMA. 2018;320:2099\u2013107.","journal-title":"JAMA"},{"key":"4903_CR17","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1001\/jama.2015.12402","volume":"314","author":"V Lemiale","year":"2015","unstructured":"Lemiale V, Mokart D, Resche-Rigon M, P\u00e8ne F, Mayaux J, Faucher E, et al. Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA. 2015;314:1711\u20139.","journal-title":"JAMA"},{"key":"4903_CR18","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1001\/jama.2021.20714","volume":"326","author":"GA Ospina-Tasc\u00f3n","year":"2021","unstructured":"Ospina-Tasc\u00f3n GA, Calder\u00f3n-Tapia LE, Garc\u00eda AF, Zarama V, G\u00f3mez-\u00c1lvarez F, \u00c1lvarez-Saa T, et al. Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. JAMA. 2021;326:2161\u201371.","journal-title":"JAMA"},{"key":"4903_CR19","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/jama.2021.4682","volume":"325","author":"DL Grieco","year":"2021","unstructured":"Grieco DL, Menga LS, Cesarano M, Ros\u00e0 T, Spadaro S, Bitondo MM, et al. Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: the HENIVOT randomized clinical trial. JAMA. 2021;325:1731\u201343.","journal-title":"JAMA"},{"key":"4903_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1164\/rccm.201111-2042ST","volume":"185","author":"MB Parshall","year":"2012","unstructured":"Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435\u201352.","journal-title":"Am J Respir Crit Care Med"},{"key":"4903_CR21","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S2213-2600(16)30093-5","volume":"4","author":"J-P Frat","year":"2016","unstructured":"Frat J-P, Ragot S, Girault C, Perbet S, Prat G, Boulain T, et al. Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial. Lancet Respir Med. 2016;4:646\u201352.","journal-title":"Lancet Respir Med"},{"key":"4903_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/CCM.0b013e3182783b72","volume":"41","author":"J Barr","year":"2013","unstructured":"Barr J, Fraser GL, Puntillo K, Ely EW, G\u00e9linas C, Dasta JF, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41:263\u2013306.","journal-title":"Crit Care Med"},{"key":"4903_CR23","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"4903_CR24","doi-asserted-by":"publisher","unstructured":"Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data: Kalbfleisch\/The statistical [Internet]. Wiley, Hoboken, NJ, USA; 2002 [cited 2022 Mar 1]. https:\/\/doi.org\/10.1002\/9781118032985.","DOI":"10.1002\/9781118032985"},{"key":"4903_CR25","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176350951.full","author":"RJ Gray","year":"1988","unstructured":"Gray RJ. A class of $K$-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988. https:\/\/doi.org\/10.1214\/aos\/1176350951.full.","journal-title":"Ann Stat"},{"key":"4903_CR26","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/0140-6736(93)90696-E","volume":"341","author":"J Bott","year":"1993","unstructured":"Bott J, Carroll MP, Conway JH, Keilty SE, Ward EM, Brown AM, et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet Lond Engl. 1993;341:1555\u20137.","journal-title":"Lancet Lond Engl"},{"key":"4903_CR27","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1164\/ajrccm.151.6.7767523","volume":"151","author":"N Kramer","year":"1995","unstructured":"Kramer N, Meyer TJ, Meharg J, Cece RD, Hill NS. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med. 1995;151:1799\u2013806.","journal-title":"Am J Respir Crit Care Med"},{"key":"4903_CR28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/00003246-199704000-00011","volume":"25","author":"S Mehta","year":"1997","unstructured":"Mehta S, Jay GD, Woolard RH, Hipona RA, Connolly EM, Cimini DM, et al. Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Crit Care Med. 1997;25:620\u20138.","journal-title":"Crit Care Med"},{"key":"4903_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jemermed.2013.08.015","volume":"46","author":"T Liesching","year":"2014","unstructured":"Liesching T, Nelson DL, Cormier KL, Sucov A, Short K, Warburton R, et al. Randomized trial of bilevel versus continuous positive airway pressure for acute pulmonary edema. J Emerg Med. 2014;46:130\u201340.","journal-title":"J Emerg Med"},{"key":"4903_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1470-2045(13)70009-3","volume":"14","author":"S Nava","year":"2013","unstructured":"Nava S, Ferrer M, Esquinas A, Scala R, Groff P, Cosentini R, et al. Palliative use of non-invasive ventilation in end-of-life patients with solid tumours: a randomised feasibility trial. Lancet Oncol. 2013;14:219\u201327.","journal-title":"Lancet Oncol"},{"key":"4903_CR31","first-page":"273","volume":"8","author":"JWH Kocks","year":"2013","unstructured":"Kocks JWH, van den Berg JWK, Kerstjens HAM, Uil SM, Vonk JM, de Jong YP, et al. Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease. Int J Chronic Obstr Pulm Dis. 2013;8:273\u201386.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"4903_CR32","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.4187\/respcare.02650","volume":"59","author":"A Tulaimat","year":"2014","unstructured":"Tulaimat A, Gueret RM, Wisniewski MF, Samuel J. Association between rating of respiratory distress and vital signs, severity of illness, intubation, and mortality in acutely ill subjects. Respir Care. 2014;59:1338\u201344.","journal-title":"Respir Care"},{"key":"4903_CR33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/crj.12191","volume":"10","author":"GR Pesola","year":"2016","unstructured":"Pesola GR, Ahsan H. Dyspnea as an independent predictor of mortality. Clin Respir J. 2016;10:142\u201352.","journal-title":"Clin Respir J"},{"key":"4903_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13049-016-0204-9","volume":"24","author":"MT B\u00f8tker","year":"2016","unstructured":"B\u00f8tker MT, Stengaard C, Andersen MS, S\u00f8ndergaard HM, Dodt KK, Niemann T, et al. Dyspnea, a high-risk symptom in patients suspected of myocardial infarction in the ambulance? A population-based follow-up study. Scand J Trauma Resusc Emerg Med. 2016;24:15.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"4903_CR35","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ahj.2012.06.026","volume":"164","author":"I Kirchberger","year":"2012","unstructured":"Kirchberger I, Heier M, Kuch B, von Scheidt W, Meisinger C. Presenting symptoms of myocardial infarction predict short- and long-term mortality: the MONICA\/KORA Myocardial Infarction Registry. Am Heart J. 2012;164:856\u201361.","journal-title":"Am Heart J"},{"key":"4903_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/thoraxjnl-2011-200332","volume":"67","author":"J Steer","year":"2012","unstructured":"Steer J, Norman EM, Afolabi OA, Gibson GJ, Bourke SC. Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax. 2012;67:117\u201321.","journal-title":"Thorax"},{"key":"4903_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165111","volume":"11","author":"M Santos","year":"2016","unstructured":"Santos M, Kitzman DW, Matsushita K, Loehr L, Sueta CA, Shah AM. Prognostic importance of dyspnea for cardiovascular outcomes and mortality in persons without prevalent cardiopulmonary disease: the atherosclerosis risk in communities study. PLoS ONE. 2016;11: e0165111.","journal-title":"PLoS ONE"},{"key":"4903_CR38","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1365-2796.2006.01631.x","volume":"259","author":"A Frostad","year":"2006","unstructured":"Frostad A, S\u00f8yseth V, Andersen A, Gulsvik A. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med. 2006;259:520\u20139.","journal-title":"J Intern Med"},{"issue":"3","key":"4903_CR39","doi-asserted-by":"publisher","first-page":"1902107","DOI":"10.1183\/13993003.02107-2019","volume":"58","author":"JP Stevens","year":"2021","unstructured":"Stevens JP, Dechen T, Schwartzstein RM, O\u2019Donnell C, Baker K, Banzett RB. Association of dyspnea, mortality, and resource use in hospitalised patients. Eur Respir J. 2021;58(3):1902107.","journal-title":"Eur Respir J"},{"key":"4903_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fmed.2018.00163","volume":"5","author":"E Dupuis-Lozeron","year":"2018","unstructured":"Dupuis-Lozeron E, Soccal PM, Janssens J-P, Similowski T, Adler D. Severe dyspnea is an independent predictor of readmission or death in COPD patients surviving acute hypercapnic respiratory failure in the ICU. Front Med. 2018;5:163.","journal-title":"Front Med"},{"key":"4903_CR41","doi-asserted-by":"publisher","first-page":"2100988","DOI":"10.1183\/13993003.00988-2021","volume":"58","author":"M Decav\u00e8le","year":"2021","unstructured":"Decav\u00e8le M, Similowski T. Dyspnoea upon hospital admission: listen to the bird of ill omen! Eur Respir J. 2021;58:2100988.","journal-title":"Eur Respir J"},{"key":"4903_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1164\/rccm.201306-1174OC","volume":"189","author":"KA Puntillo","year":"2014","unstructured":"Puntillo KA, Max A, Timsit J-F, Vignoud L, Chanques G, Robleda G, et al. Determinants of procedural pain intensity in the intensive care unit. The Europain\u00ae study. Am J Respir Crit Care Med. 2014;189:39\u201347.","journal-title":"Am J Respir Crit Care Med"},{"key":"4903_CR43","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1097\/CCM.0b013e31821e8779","volume":"39","author":"M Schmidt","year":"2011","unstructured":"Schmidt M, Demoule A, Polito A, Porchet R, Aboab J, Siami S, et al. Dyspnea in mechanically ventilated critically ill patients. Crit Care Med. 2011;39:2059\u201365.","journal-title":"Crit Care Med"},{"key":"4903_CR44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.chest.2019.04.128","volume":"156","author":"JP Stevens","year":"2019","unstructured":"Stevens JP, Sheridan AR, Bernstein HB, Baker K, Lansing RW, Schwartzstein RM, et al. A multidimensional profile of dyspnea in hospitalized patients. Chest. 2019;156:507\u201317.","journal-title":"Chest"},{"key":"4903_CR45","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/00003246-200204000-00004","volume":"30","author":"AJ Rotondi","year":"2002","unstructured":"Rotondi AJ, Chelluri L, Sirio C, Mendelsohn A, Schulz R, Belle S, et al. Patients\u2019 recollections of stressful experiences while receiving prolonged mechanical ventilation in an intensive care unit. Crit Care Med. 2002;30:746\u201352.","journal-title":"Crit Care Med"},{"key":"4903_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/CCM.0b013e3181feb824","volume":"39","author":"S de Miranda","year":"2011","unstructured":"de Miranda S, Pochard F, Chaize M, Megarbane B, Cuvelier A, Bele N, et al. Postintensive care unit psychological burden in patients with chronic obstructive pulmonary disease and informal caregivers: a multicenter study. Crit Care Med. 2011;39:112\u20138.","journal-title":"Crit Care Med"},{"key":"4903_CR47","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1164\/rccm.202108-1857OC","volume":"205","author":"A Demoule","year":"2022","unstructured":"Demoule A, Hajage D, Messika J, Jaber S, Diallo H, Coutrot M, et al. Prevalence, intensity, and clinical impact of dyspnea in critically ill patients receiving invasive ventilation. Am J Respir Crit Care Med. 2022;205:917\u201326.","journal-title":"Am J Respir Crit Care Med"},{"key":"4903_CR48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1136\/thoraxjnl-2013-204701","volume":"69","author":"DC Currow","year":"2014","unstructured":"Currow DC, Abernethy AP, Ko DN. The active identification and management of chronic refractory breathlessness is a human right. Thorax. 2014;69:393\u20134.","journal-title":"Thorax"},{"key":"4903_CR49","doi-asserted-by":"publisher","first-page":"1602099","DOI":"10.1183\/13993003.02099-2016","volume":"49","author":"M Ba\u015fo\u011flu","year":"2017","unstructured":"Ba\u015fo\u011flu M. Effective management of breathlessness: a review of potential human rights issues. Eur Respir J. 2017;49:1602099.","journal-title":"Eur Respir J"},{"key":"4903_CR50","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1164\/rccm.201805-0996OC","volume":"199","author":"ER Gentzler","year":"2019","unstructured":"Gentzler ER, Derry H, Ouyang DJ, Lief L, Berlin DA, Xu CJ, et al. Underdetection and undertreatment of dyspnea in critically ill patients. Am J Respir Crit Care Med. 2019;199:1377\u201384.","journal-title":"Am J Respir Crit Care Med"}],"updated-by":[{"DOI":"10.1186\/s13054-025-05314-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000}}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-04903-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-024-04903-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-04903-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T05:30:52Z","timestamp":1742967052000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-024-04903-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4903"],"URL":"https:\/\/doi.org\/10.1186\/s13054-024-04903-5","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13054-025-05314-w","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"16 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13054-025-05314-w","URL":"https:\/\/doi.org\/10.1186\/s13054-025-05314-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The original parent trial was approved by ethics committees at Centre Hospitalier Universitaire de Poitiers for French study sites (n. 10.11.28, 28 December 2010) and at Cliniques Universitaires Saint-Luc, Brussels for the site in Belgium (n. 10.07.12, 3 May 2011). Written informed consent was obtained from all the patients, their next of kin or another surrogate decision-maker as appropriate. According to French law, this post hoc analysis of the original study did not need additional ethics approval as no more data were collected for this analysis. Procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as most recently amended.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A Demoule reports grants from French Ministry of Health, Assistance publique\u2014H\u00f4pitaux de Paris, Lungpacer, Respinor, consulting fees from Respinor, Lungpacer, Lowenstein, Tribunal administrative de Cergy, Liberate Medical, Payment or honoraria for lectures, presentations from Fisher & Paykel, Baxter, Getinge, Astra, Agence Europ\u00e9enne Informatique, Mindray, support for attending meetings and\/or travel from Lungpacer, outside the submitted work. A Baptiste has nothing to disclose. AW Thille reports payment or honoraria for lectures, presentations Fisher & Paykel, GE Healthcare, Philips, support for attending meetings and\/or travel Fisher & Paykel, GE Healthcare, outside the submitted work. T Similowski reports grants from Lungpacer, consulting fees from ADEP Assistance, AstraZeneca France, Chiesi France, KPL consulting, Lungpacer Inc., Novartis France, TEVA France, Vitalaire, outside the submitted work. S Ragot has nothing to disclose G Prat has nothing to disclose A Mercat has nothing to disclose. C Girault reports payment or honoraria for lectures, presentations from Air Liquide Medical System, Medtronic, Dr\u00e4ger, support for attending meetings and\/or travel from Fisher & Paykel, GE healthcare, Air Liquide Medical System, outside the submitted work. G Carteau reports payment or honoraria for lectures, presentations Air Liquide Medical System Medtronic Dr\u00e4ger, support for attending meetings and\/or travel from Air Liquide Medical System outside the submitted work. T Boulain has nothing to disclose. S Perbet has nothing to disclose. L Belin has nothing to disclose. JP Frat reports non-financial support from Fisher and Paykel Healthcare (the firm provided material and equipment to all the participating centers), grant from the French Ministry of Heath, AADAIRC, French society of intensive care for the parent study, grants from the French Ministry of Heath, Fisher and Paykel Healthcare, consulting fees from SOS Oxygene, payment or honoraria for lectures from Fisher and Paykel Healthcare, support for attending meetings and\/or travel from Fisher and Paykel Healthcare and SOS Oxygene, outside the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}